118
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Psoralen-loaded lipid-polymer hybrid nanoparticles enhance doxorubicin efficacy in multidrug-resistant HepG2 cells

, , , , , , , , , & show all
Pages 2207-2218 | Published online: 27 Mar 2019

References

  • ZhangYQuCRenJZhangSWangYDaiMLiver cancer incidence and mortality data set in ChinaZhonghua Zhong Liu Za Zhi2015379705720 Chinese26813437
  • ChenivesseXFrancoDBréchotCMDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosisJ Hepatol19931821681728409332
  • GottesmanMMPastanIBiochemistry of multidrug resistance mediated by the multidrug transporterAnnu Rev Biochem19936213854278102521
  • ComerfordKMWallaceTJKarhausenJLouisNAMontaltoMCColganSPHypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) geneCancer Res200262123387339412067980
  • ParkJGLeeSKHongIGMDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell linesJ Natl Cancer Inst19948697007057908989
  • WangLMoselAJOakleyGGPengALingWDeficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancerMol Cancer Ther201211112401240922973056
  • MaitiAKGenetic determinants of oxidative stress-mediated sensitization of drug-resistant cancer cellsInt J Cancer201213011921792891
  • DahdouhFRaaneMThévenodFLeeWKNickel-induced cell death and survival pathways in cultured renal proximal tubule cells: roles of reactive oxygen species, ceramide and ABCB1Arch Toxicol201488488189224448832
  • DempseyCERobertsDLDiveCBax, Bak and Bid: Key Mediators of ApoptosisWiley-VCH Verlag GmbH2008
  • YouleRJStrasserARjYThe Bcl-2 protein family: opposing activities that mediate cell deathNat Rev Mol Cell Biol200891475918097445
  • HsiehMJChenMKYuYYSheuGTChiouHLPsoralen reverses docetaxel-induced multidrug resistance in A549/D16 human lung cancer cells linesPhytomedicine201421797097724703328
  • CaiJChenSZhangWPaeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2Phytomedicine201421798499124680370
  • DavisMEChenZGShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
  • HillaireauHCouvreurPNanocarriers’ entry into the cell: relevance to drug deliveryCell Mol Life Sci200966172873289619499185
  • BaiFWangCLuQNanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancerBiomaterials201334266163617423706689
  • WangYKhoKCheowWSHadinotoKA comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticlesInt J Pharm20124241–29810622226876
  • GaoJXiaYChenHPolymer-lipid hybrid nanoparticles conjugated with anti-EGF receptor antibody for targeted drug delivery to hepatocellular carcinomaNanomedicine20149227929323721168
  • LiuYPanJFengSSNanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performanceInt J Pharm20103951–224325020472049
  • ThevenotJTroutierALDavidLDelairTLadavièreCSteric stabilization of lipid/polymer particle assemblies by poly(ethylene glycol)-lipidsBiomacromolecules20078113651366017958441
  • ZhangLZhuDDongXFolate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel deliveryInt J Nanomedicine2015102101211425844039
  • FengSSChienSChemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseasesChem Eng Sci2003581840874114
  • ZhangLChanJMGuFXSelf-assembled lipid–polymer hybrid nanoparticles: a robust drug delivery platformACS Nano2008281696170219206374
  • WuXYXyWStrategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug deliveryExpert Opin Drug Deliv201613560961226978527
  • TangCZhangELiYYangLAn innovative method for preparation of hydrophobic ion-pairing colistin entrapped poly(lactic acid) nanoparticles: loading and release mechanism studyEur J Pharm Sci2017102637028254391
  • LuHZhangLLiuDTangPSongFIsolation and purification of psoralen and isopsoralen and their efficacy and safety in the treatment of osteosarcoma in nude ratsAfr Health Sci201414364164725352883
  • CheowWSHadinotoKFactors affecting drug encapsulation and stability of lipid–polymer hybrid nanoparticlesColloids Surf B: Biointerfaces201185221422021439797
  • HanMVakiliMRSoleymani AbyanehHMolaviOLaiRLavasanifarAMitochondrial delivery of doxorubicin via triphe-nylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cellsMol Pharm20141182640264924811541
  • KroemerGReedJCMitochondrial control of cell deathNat Med20006551351910802706
  • LeytinVMykhaylovSStarkeyAFIntravenous immunoglobulin inhibits anti-glycoprotein IIb-induced platelet apoptosis in a murine model of immune thrombocytopeniaBr J Haematol20061331060207074859002060207074859082
  • YuanYChibaPCaiTFabrication of psoralen-loaded lipid-polymer hybrid nanoparticles and their reversal effect on drug resistance of cancer cellsOncol Rep20184021055106329901161
  • SkałaEKowalczykTTomaMInduction of apoptosis in human glioma cell lines of various grades through the ROS-mediated mitochondrial pathway and caspase activation by Rhaponticum carthamoides transformed root extractMol Cell Biochem20184451–2899729238899
  • Forbes-HernándezTYGiampieriFGasparriniMThe effects of bioactive compounds from plant foods on mitochondrial function: a focus on apoptotic mechanismsFood Chem Toxicol20146815418224680691
  • JeffersMRongSvande WoudeGFHepatocyte growth factor/scatter factor-MET signaling in tumorigenicity and invasion/metastasisJ Mol Med19967495055138892055
  • JakubowskaJWasowska-LukawskaMCzyzMSTI571 and morpho-line derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochondrial pathway of apoptosisEur J Pharmacol20085961–3414918782571
  • WangYHongCZhouCXuDQuH-BScreening antitumor compounds psoralen and isopsoralen from Psoralea corylifolia L. seedsEvid Based Compl Alternative Med20112011517
  • KiJCJoerges ChristophKIHerzinge Thomas induction of a caffeine-sensitive S-phase cell cycle checkpoint by psoralen plus ultraviolet A radiationOncogene2003229
  • WangXChengKHanYEffects of psoralen as an anti-tumor agent in human breast cancer MCF-7/ADR cellsBiol Pharm Bull201639581582226902225
  • JiangJWangXChengKPsoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cellsMol Med Rep20161364745475027082231
  • WangHGaoZLiuXTargeted production of reactive oxygen species in mitochondria to overcome cancer drug resistanceNat Commun20189156229422620
  • CuiHHuanMLYeWLMitochondria and nucleus dual delivery system to overcome Dox resistanceMol Pharm201714374675628146635
  • LiuYZhangXZhouMNanXChenXZhangXMitochondrial-targeting Lonidamine-Doxorubicin nanoparticles for synergistic chemotherapy to conquer drug resistanceACS Appl Mater Interfaces2017950434984350729171954
  • LosMMozolukMFerrariDActivation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signalingMol Biol Cell200213397898811907276
  • PawlowskiJKraftASBax-induced apoptotic cell deathProc Natl Acad Sci200097252953110639111
  • ZhangJHuJChanHFSkibbaMLiangGChenMiRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacyNanomedicine20161251303131126964482